PLIVA d.d. announced today that its affiliates PAM Kft. and PLIVA CROATIA Ltd. have entered into a strategic collaboration with Mayne Pharma, a leading international hospital generics company, for the development, supply and marketing of PLIVA’s two most advanced followon biologics programs, erythropoietin (EPO) and granulocyte colony stimulating factor (“G-CSF”).